GO:0032052 bile acid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032052 (bile acid binding) is a molecular_function term defined as binding to a bile acid, a steroid carboxylic acid occurring in bile.
• Bile acid binding is mediated by dedicated proteins such as ileal bile acid-binding protein (I-BABP/FABP6), liver fatty acid-binding protein (FABP1), and nuclear receptors like FXR (NR1H4), which recognize bile acids with high specificity.
• The structural and dynamic determinants of molecular recognition in bile acid-binding proteins involve conformational plasticity and specific hydrogen-bonding networks.
• Bile acid binding is central to cholesterol homeostasis, intestinal bile acid reabsorption, and enterohepatic circulation, with I-BABP playing a key role.
• Dysregulation of bile acid binding contributes to cholestasis, bile acid diarrhea, and metabolic disorders; targeting bile acid overload pathways is a therapeutic strategy.
• Experimental approaches to study bile acid binding include binding assays, structural biology (NMR, crystallography), CRISPR knockout/knock-in models, and dietary fiber binding capacity assays.
Description
Bile acid binding (GO:0032052) is a molecular function that describes the selective interaction of a protein or other molecule with a bile acid, a steroid carboxylic acid found in bile. This function is fundamental to the enterohepatic circulation of bile acids, cholesterol homeostasis, and the regulation of lipid metabolism. Proteins capable of bile acid binding include intracellular lipid-binding proteins such as ileal bile acid-binding protein (I-BABP, gene FABP6) and liver fatty acid-binding protein (FABP1), as well as nuclear receptors like farnesoid X receptor (FXR, gene NR1H4) and membrane transporters. Understanding bile acid binding is essential for deciphering how organisms manage bile acid pools, respond to dietary lipids, and maintain metabolic balance. Dysregulation of bile acid binding is implicated in cholestasis, bile acid diarrhea, and metabolic diseases, making it a target for therapeutic intervention. Moreover, bile acid binding capacity is a property exploited in dietary fibers and polymeric sequestrants to lower cholesterol. This article provides a comprehensive overview of the molecular mechanism, key genes, disease relevance, and research methods for studying bile acid binding, based on authoritative QuickGO data and verified PubMed literature.
bile acid binding At A Glance
| GO ID | GO:0032052 |
|---|---|
| GO term | bile acid binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a bile acid, a steroid carboxylic acids occurring in bile. |
| Major function | Selective recognition and interaction with bile acids for transport, signaling, and homeostasis. |
| Related genes/proteins | FABP6 (I-BABP), FABP1 (L-FABP), NR1H4 (FXR), SLCO1B1, SLCO1B3, ABST, etc. |
| Associated diseases | Cholestasis, bile acid diarrhea, hypercholesterolemia, metabolic syndrome. |
| Research methods | Isothermal titration calorimetry, NMR, X-ray crystallography, CRISPR screens, binding assays. |
What Is GO:0032052?
According to the Gene Ontology, GO:0032052 (bile acid binding) is defined as the molecular function of binding to a bile acid, which is a steroid carboxylic acid occurring in bile. This term encompasses the selective and non-covalent interaction between a binding agent (protein, peptide, or synthetic polymer) and bile acid molecules such as cholic acid, chenodeoxycholic acid, or their conjugated forms. The binding event is a prerequisite for bile acid transport, signaling, and metabolism.
Why Is bile acid binding Important in Cell Biology?
Bile acid binding is a critical molecular function that underpins the body's ability to manage bile acids, which are essential for digestion and absorption of dietary fats and fat-soluble vitamins. It is central to cholesterol catabolism and the enterohepatic circulation, and it modulates signaling pathways that control lipid and glucose metabolism. Defects in bile acid binding proteins can lead to cholestasis, diarrhea, and metabolic disorders, while enhancing bile acid binding in the gut can lower cholesterol. Thus, understanding this function has broad implications for gastroenterology, hepatology, and metabolic disease research.
• Regulates cholesterol homeostasis by controlling bile acid reabsorption and synthesis.
• Mediates intestinal bile acid transport and enterohepatic circulation.
• Involved in bile acid diarrhea pathogenesis due to impaired binding/transport.
• Target for polymeric bile acid sequestrants used to lower cholesterol.
• Dietary fibers with bile acid binding capacity can modulate lipid metabolism.
• Bile acid binding by norovirus capsid protein affects viral entry and pathogenesis.
• Bile acid transporters are exploited for oral drug delivery.
• Dysregulation contributes to cholestasis and liver injury.
• Provides structural insights into molecular recognition and protein dynamics.
• Enables development of CRISPR models to study gene function in bile acid metabolism.
Molecular Mechanism of bile acid binding
Substrate recognition and binding site architecture
In simple terms: Bile acid binding proteins have a pocket that fits bile acids like a lock and key.
Bile acid-binding proteins such as I-BABP and FABP1 possess a hydrophobic binding cavity that accommodates the steroid nucleus of bile acids. Structural studies reveal that the binding site is lined with aromatic and hydrophobic residues that interact with the sterol core, while polar residues form hydrogen bonds with the carboxylate group and hydroxyl moieties of bile acids. The dynamic nature of these proteins allows conformational adjustments upon ligand binding, as observed by NMR chemical-shift perturbations.
Conformational dynamics and allostery
In simple terms: The protein changes shape when it binds a bile acid, which can affect how it works.
Bile acid binding is not a static event; it involves conformational changes that can propagate through the protein. For example, chemical-shift perturbation studies on norovirus coat protein showed that bile acid binding induces local and long-range structural changes. In I-BABP, ligand binding alters the dynamics of the portal region, influencing its interaction with membranes or other partners. These dynamic determinants are crucial for molecular recognition and function.
Cofactors and regulatory ions
In simple terms: Some bile acid binding proteins need helper molecules or ions to work properly.
While many bile acid-binding proteins function without cofactors, some nuclear receptors like FXR require heterodimerization with RXR and binding to DNA response elements to regulate transcription upon bile acid binding. The binding of bile acids to FXR triggers conformational changes that recruit coactivators. In transporters, ion gradients (e.g., sodium) drive bile acid uptake, coupling binding to transport.
Regulation of bile acid binding activity
In simple terms: Cells can control how much bile acid binding protein they make or how active it is.
The expression of bile acid-binding proteins is regulated at transcriptional and post-transcriptional levels. For instance, FXR activation by bile acids induces expression of I-BABP in the ileum, creating a feedback loop. Additionally, bile acid overload can modulate signaling pathways such as LXRβ, affecting ceramide metabolism and cholestasis. Post-translational modifications and membrane localization also regulate binding activity.
Binding specificity and affinity
In simple terms: Different proteins prefer different bile acids, and they hold on with varying strength.
Bile acid-binding proteins exhibit distinct specificities for different bile acid species. I-BABP preferentially binds conjugated bile acids such as taurocholate, while FABP1 binds a broader range of bile acids and fatty acids. Binding affinities (Kd) range from low micromolar to nanomolar, determined by the interplay of hydrophobic and electrostatic interactions. These differences are critical for their physiological roles in bile acid transport and signaling.
Key Genes Involved in GO:0032052 bile acid binding
The following genes encode proteins that directly bind bile acids or are intimately involved in bile acid binding-related processes, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FABP6 (I-BABP) | Ileal bile acid-binding protein; binds bile acids in enterocytes | Key mediator of intestinal bile acid reabsorption; target for cholesterol and diarrhea research |
| FABP1 (L-FABP) | Liver fatty acid-binding protein; binds bile acids and fatty acids | Involved in hepatic bile acid handling and lipid metabolism |
| NR1H4 (FXR) | Nuclear receptor activated by bile acids; regulates bile acid synthesis and transport | Central regulator of bile acid homeostasis; drug target for cholestasis and metabolic disease |
| SLCO1B1 (OATP1B1) | Sodium-independent organic anion transporter; transports bile acids | Mediates hepatic uptake of bile acids; pharmacogenetics relevance |
| SLCO1B3 (OATP1B3) | Organic anion transporter; transports bile acids | Expressed in liver and intestine; involved in bile acid and drug transport |
| ABST (ASBT/SLC10A2) | Apical sodium-dependent bile acid transporter | Mediates intestinal bile acid uptake; target for bile acid diarrhea |
| NR0B2 (SHP) | Small heterodimer partner; interacts with FXR to repress bile acid synthesis | Feedback regulation of bile acid synthesis |
| CYP7A1 | Cholesterol 7-alpha-hydroxylase; rate-limiting enzyme in bile acid synthesis | Regulated by bile acid binding to FXR; links cholesterol to bile acid production |
| CYP8B1 | Sterol 12-alpha-hydroxylase; determines bile acid composition | Affects bile acid pool and binding properties |
| ABCG5/ABCG8 | Sterol transporters; export cholesterol and plant sterols | Indirectly affect bile acid synthesis and binding |
| ACER3 | Alkaline ceramidase 3; modulates bile acid overload via LXRβ signaling | Target for cholestasis therapy; links sphingolipid and bile acid metabolism |
| NR1H2 (LXRβ) | Liver X receptor beta; regulates cholesterol and bile acid metabolism | Involved in bile acid overload response; potential therapeutic target |
| SLC10A1 (NTCP) | Sodium-taurocholate cotransporting polypeptide; hepatic bile acid uptake | Key transporter for bile acid binding and enterohepatic circulation |
| VDR | Vitamin D receptor; binds bile acids as ligands | Modulates bile acid detoxification and intestinal homeostasis |
| PXR (NR1I2) | Pregnane X receptor; activated by bile acids and xenobiotics | Regulates bile acid detoxification enzymes |
| CAR (NR1I3) | Constitutive androstane receptor; binds bile acids | Involved in bile acid and drug metabolism |
| Norovirus capsid protein | Binds bile acids to facilitate infection | Model for studying bile acid binding in viral entry |
| Dietary fiber components | Non-protein bile acid binders | Used to study bile acid sequestration and cholesterol lowering |
How Is bile acid binding Regulated?
Bile acid binding is regulated at multiple levels. Transcriptional regulation of bile acid-binding proteins such as FABP6 is controlled by FXR, which is activated by bile acids themselves, forming a feedback loop. Post-translational modifications and membrane trafficking can alter the availability of transporters like ASBT and NTCP. Additionally, bile acid overload can trigger signaling cascades involving LXRβ and ceramide metabolism, which modulate bile acid binding and detoxification pathways. Polymeric bile acid sequestrants and dietary fibers can also regulate bile acid binding in the gut by sequestering bile acids and preventing their reabsorption.
bile acid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FABP6 | Bile acid diarrhea, cholesterol homeostasis | Fabp6 knockout mouse; intestinal organoids |
| NR1H4 (FXR) | Cholestasis, metabolic syndrome | Fxr knockout mouse; liver-specific overexpression |
| ACER3 | Cholestasis, bile acid overload | Acer3 knockout mouse; LXRβ signaling studies |
| SLCO1B1 | Hypercholesterolemia, drug-induced myopathy | Slco1b1 knockout mouse; human hepatocytes |
| Norovirus capsid | Viral gastroenteritis | Norovirus replicon; bile acid binding assays |
Bile acid diarrhea
Bile acid diarrhea (BAD) is a common cause of chronic diarrhea, resulting from impaired bile acid absorption in the ileum or excessive bile acid synthesis. Defects in ileal bile acid-binding protein (I-BABP) or the apical sodium-dependent bile acid transporter (ASBT) can lead to bile acid malabsorption, increasing colonic bile acid concentrations and inducing secretory diarrhea. Diagnosis and management often involve bile acid sequestrants that bind bile acids in the gut.
Cholestasis and liver injury
Cholestasis is characterized by impaired bile flow and accumulation of bile acids in the liver, leading to hepatocyte injury. Bile acid binding proteins and transporters play protective roles by facilitating bile acid efflux and detoxification. Recent studies show that targeting ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling, highlighting the interplay between bile acid binding and sphingolipid metabolism.
Hypercholesterolemia and metabolic syndrome
Bile acid sequestrants, such as polymeric resins, bind bile acids in the intestine and promote their excretion, forcing the liver to convert cholesterol into new bile acids, thereby lowering plasma cholesterol. Dietary fibers with bile acid binding capacity, such as those from amaranth, have shown hypocholesterolemic effects in vitro and in animal models. Thus, bile acid binding is a therapeutic target for managing hypercholesterolemia and related metabolic disorders.
Viral infection
Norovirus, a major cause of gastroenteritis, uses bile acids as cofactors for infection. The norovirus capsid protein binds bile acids, and this interaction is required for efficient viral entry into host cells. Chemical-shift perturbation studies have revealed that bile acid binding induces conformational changes in the capsid protein, providing insights into viral pathogenesis and potential antiviral targets.
From bile acid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FABP6 mediate intestinal bile acid reabsorption? | Fabp6 knockout mouse or Caco-2 cells with CRISPR knockout |
| How does FXR activation affect bile acid binding protein expression? | Fxr knockout mouse; FXR agonist treatment in wild-type |
| What is the effect of ACER3 loss on bile acid overload? | Acer3 knockout mouse; cholestasis models |
| Can a point mutation in FABP6 alter bile acid binding affinity? | CRISPR point-mutation knock-in in cell lines; recombinant protein binding assays |
| Does overexpression of I-BABP protect against bile acid diarrhea? | Transgenic mouse overexpressing Fabp6 in intestine |
| How do bile acid sequestrants affect bile acid binding in vivo? | Polymeric sequestrant administration in animal models; fecal bile acid analysis |
How to Study the bile acid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry (ITC) | Binding affinity (Kd), stoichiometry, thermodynamics | Characterize bile acid binding to purified proteins |
| NMR chemical-shift perturbation | Binding site mapping, conformational changes | Study dynamic recognition in bile acid-binding proteins |
| X-ray crystallography | High-resolution 3D structure of protein-bile acid complex | Determine atomic details of binding pocket |
| CRISPR knockout | Loss-of-function phenotype | Test gene requirement for bile acid binding/transport |
| CRISPR knock-in (point mutation) | Effect of specific mutation on binding | Validate structural determinants of bile acid binding |
| Bile acid profiling (LC-MS) | Concentration of bile acid species | Assess impact of genetic or dietary interventions |
| Dietary fiber bile acid binding assay | Binding capacity of fibers | Evaluate cholesterol-lowering potential |
| Polymeric sequestrant binding assay | In vitro bile acid sequestration | Develop hypocholesterolemic agents |
Binding assays for bile acid interaction
Direct measurement of bile acid binding can be performed using isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), or fluorescence quenching. These methods provide quantitative binding affinities (Kd) and stoichiometry. For example, ITC has been used to characterize bile acid binding to I-BABP and norovirus capsid protein. Radiolabeled bile acid binding assays are also common for transporters and dietary fibers.
Structural biology: NMR and crystallography
NMR spectroscopy, particularly chemical-shift perturbation, is powerful for mapping bile acid binding sites and detecting conformational changes in solution. X-ray crystallography provides high-resolution structures of protein-bile acid complexes, revealing atomic details of the binding pocket. These methods are essential for understanding molecular recognition determinants.
CRISPR-based functional genomics
CRISPR knockout and knock-in models enable the study of genes involved in bile acid binding in a physiological context. For instance, knocking out FABP6 or NR1H4 in cell lines or mice can reveal their roles in bile acid transport and signaling. CRISPR screens can identify novel genes that modulate bile acid binding capacity or bile acid-induced toxicity.
Bile acid profiling and metabolomics
Mass spectrometry-based bile acid profiling quantifies individual bile acid species in biological samples, providing insights into the impact of bile acid binding on pool composition and metabolism. This approach is used in studies of cholestasis, diarrhea, and metabolic disease. Combining metabolomics with genetic models helps link bile acid binding function to physiological outcomes.
How CRISPR Can Be Used to Study GO:0032052 bile acid binding
Knockout
CRISPR knockout of genes encoding bile acid-binding proteins (e.g., FABP6, NR1H4) allows researchers to assess their necessity in bile acid homeostasis. For example, Fabp6 knockout mice exhibit altered bile acid absorption and are used to study bile acid diarrhea. Knockout cell lines can be used for binding assays and metabolic profiling.
Point Mutation
Introducing specific point mutations in bile acid-binding proteins via CRISPR can validate structural determinants of binding. For instance, mutating residues in the binding pocket of I-BABP can reveal their contribution to bile acid affinity and specificity. Such models are valuable for dissecting molecular recognition mechanisms.
Knock-in
Knock-in of tagged or reporter versions of bile acid-binding proteins enables real-time tracking of protein localization and interactions. For example, a fluorescently tagged FABP6 knock-in can be used to visualize bile acid binding dynamics in live cells. Knock-in of humanized alleles can also model human-specific bile acid metabolism.
Overexpression
Overexpression of bile acid-binding proteins such as I-BABP or FXR in cell lines or animal models can enhance bile acid binding capacity and modulate downstream signaling. This approach is used to study the protective effects of bile acid sequestration in cholestasis and metabolic disease.
How EDITGENE Supports bile acid binding Research
Researchers studying bile acid binding-related genes often need to determine whether a candidate gene is causally involved in bile acid transport, signaling, or metabolism. CRISPR-based models provide a robust way to test gene function in relevant cell types and animal models, enabling precise mechanistic insights and therapeutic target validation.
Contact EDITGENE today to design your custom CRISPR model for bile acid binding research.
Frequently Asked Questions About bile acid binding
What is bile acid binding (GO:0032052)?
Bile acid binding is a molecular function defined by the Gene Ontology as binding to a bile acid, a steroid carboxylic acid occurring in bile. It involves selective interaction between proteins or other molecules and bile acids.
What genes are involved in bile acid binding?
Key genes include FABP6 (I-BABP), FABP1 (L-FABP), NR1H4 (FXR), SLCO1B1, SLCO1B3, SLC10A2 (ASBT), and ACER3, among others.
How is bile acid binding studied experimentally?
Common methods include isothermal titration calorimetry, NMR spectroscopy, X-ray crystallography, CRISPR knockout/knock-in models, and bile acid profiling by mass spectrometry.
What diseases are associated with defective bile acid binding?
Defective bile acid binding is linked to bile acid diarrhea, cholestasis, hypercholesterolemia, and metabolic syndrome.
What is the role of FABP6 in bile acid binding?
FABP6 encodes ileal bile acid-binding protein (I-BABP), which binds bile acids in the intestine and is crucial for their reabsorption and enterohepatic circulation.
How does FXR (NR1H4) bind bile acids?
FXR is a nuclear receptor that binds bile acids as ligands, triggering conformational changes that regulate gene expression involved in bile acid synthesis and transport.
Can dietary fibers bind bile acids?
Yes, certain dietary fibers, such as those from amaranth, have bile acid binding capacity and can lower cholesterol by sequestering bile acids in the gut.
What are polymeric bile acid sequestrants?
Polymeric bile acid sequestrants are synthetic resins that bind bile acids in the intestine, promoting their excretion and lowering plasma cholesterol.
How does bile acid binding affect drug delivery?
Bile acid transporters can be exploited for oral drug delivery by conjugating drugs to bile acids, enhancing intestinal absorption.
What CRISPR models are available for bile acid binding research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for genes like FABP6, NR1H4, and ACER3, as well as CRISPR library screening services.
Conclusion
Bile acid binding (GO:0032052) is a fundamental molecular function with broad implications for cholesterol homeostasis, intestinal physiology, and disease. The structural and dynamic determinants of bile acid recognition have been elucidated for several proteins, and CRISPR-based models are accelerating functional studies. Targeting bile acid binding pathways holds promise for treating cholestasis, diarrhea, and metabolic disorders. EDITGENE provides comprehensive CRISPR services to support mechanistic and therapeutic research in this field.
References
- 1. Toke O. 2022. Structural and Dynamic Determinants of Molecular Recognition in Bile Acid-Binding Proteins.. Int J Mol Sci 23(1) PMID: 35008930
- 2. Heřmánková E et al.. 2018. Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects.. Eur J Med Chem 144:300-317 PMID: 29275230
- 3. Potter GD. 1998. Bile acid diarrhea.. Dig Dis 16(2):118-24 PMID: 9571377
- 4. Sabbione AC et al.. 2024. Characterization and Bile Acid Binding Capacity of Dietary Fiber Obtained from Three Different Amaranth Products.. Plant Foods Hum Nutr 79(1):38-47 PMID: 37938455
- 5. Creutznacher R et al.. 2020. Chemical-Shift Perturbations Reflect Bile Acid Binding to Norovirus Coat Protein: Recognition Comes in Different Flavors.. Chembiochem 21(7):1007-1021 PMID: 31644826
- 6. Deng F et al.. 2020. Bile acid transporter-mediated oral drug delivery.. J Control Release 327:100-116 PMID: 32711025
- 7. Besnard P et al.. 2004. [Is the ileal bile acid-binding protein (I-BABP) gene involved in cholesterol homeostasis?].. Med Sci (Paris) 20(1):73-7 PMID: 14770367
- 8. Liao L et al.. 2025. Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction.. Nat Commun 16(1):2112 PMID: 40025008
